cilostazol

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50268-176
  • Package NDC 50268-176-15
  • Application number ANDA077030
  • SPL ID 47bc4cad-6c05-e6d6-e063-6294a90a5c2d
  • SPL set ID aec462c8-e225-f520-cae5-80049151c0ff
  • UNII N7Z035406B
  • RxCUI 242461
  • RxCUI 242462

What the source publishes

Labeler
AvPAK
Active ingredients
cilostazol
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50268-176_47bc4cad-6c05-e6d6-e063-6294a90a5c2d
{
  "name": "cilostazol",
  "splId": "47bc4cad-6c05-e6d6-e063-6294a90a5c2d",
  "labels": [
    {
      "setId": "aec462c8-e225-f520-cae5-80049151c0ff",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aec462c8-e225-f520-cae5-80049151c0ff",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aec462c8-e225-f520-cae5-80049151c0ff"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AvPAK",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-176-15)  / 1 TABLET in 1 BLISTER PACK (50268-176-11)",
      "package_ndc": "50268-176-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20161018"
    }
  ],
  "productId": "50268-176_47bc4cad-6c05-e6d6-e063-6294a90a5c2d",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "50268-176",
  "deaSchedule": null,
  "genericName": "cilostazol",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CILOSTAZOL",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "ANDA077030",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20161018",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175598",
      "N0000175086"
    ],
    "unii": [
      "N7Z035406B"
    ],
    "rxcui": [
      "242461",
      "242462"
    ],
    "spl_set_id": [
      "aec462c8-e225-f520-cae5-80049151c0ff"
    ],
    "pharm_class_epc": [
      "Phosphodiesterase 3 Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Phosphodiesterase 3 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "AvPAK"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50268-176_47bc4cad-6c05-e6d6-e063-6294a90a5c2d"